Cover Image

Effects and Optimal Dose of Exercise on Endothelial Function in Patients with Heart Failure: A Systematic Review and Meta-Analysis

Abstract Background Exercise-based cardiac rehabilitation (CR) is considered an effective treatment for enhancing endothelial function in patients with heart failure (HF). However, recent studies have been published and the optimal "dose" of exercise required to increase the benefits of ex...

Full description

Saved in:

Bibliographic Details
Main Authors:	Laura Fuertes-Kenneally (Author), Agustín Manresa-Rocamora (Author), Carles Blasco-Peris (Author), Fernando Ribeiro (Author), Noemí Sempere-Ruiz (Author), José Manuel Sarabia (Author), Vicente Climent-Paya (Author)
Format:	Book
Published:	SpringerOpen, 2023-02-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Influence of the exercise frequency, intensity, time and type according to different training modalities on the cardiac rehabilitation programs
by: José Manuel Sarabia, et al.
Published: (2018)

The Relationship of Endothelial Dysfunction with the Development of Diastolic Heart Failure in Patients with Hypertension
by: T. V. Kalinkina, et al.
Published: (2020)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020)

Serum uric acid as a metabolic regulator of endothelial function in heart failure
by: Alexander E Berezin
Published: (2017)

ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION
by: A. N. Zakirova, et al.
Published: (2015)

ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION
by: A. N. Zakirova, et al.
Published: (2015)

Dynamics of Vascular Stiffness and Endothelial Function in Combination Therapy of Heart Failure with Preserved Ejection Fraction
by: Z. M. Akhilgova, et al.
Published: (2020)

Interrelation of galectin-3 and circulating proangiogenic endothelial cells in patients with ischemic chronic heart failure
by: A. A. Kremzer
Published: (2014)

Optimization of GDMT for patients with heart failure and reduced ejection fraction: can physiological and biological barriers explain the gaps in adherence to heart failure guidelines?
by: Marilyne Jarjour, et al.
Published: (2023)

Short-term effect of sacubitril/valsartan on endothelial dysfunction and arterial stiffness in patients with chronic heart failure
by: Velia Cassano, et al.
Published: (2022)

Endothelial Microvascular Dysfunction and Its Relationship with Haptoglobin Levels in Patients with Different Phenotypes of Chronic Heart Failure
by: V. I. Podzolkov, et al.
Published: (2021)

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE
by: A. N. Zakirova, et al.
Published: (2015)

EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE
by: A. N. Zakirova, et al.
Published: (2015)

Circulating endothelial progenitor cells as a marker of left ventricular pump function in ischemic chronic heart failure
by: A. A. Kremzer
Published: (2017)

Indicators of endothelial function and systemic immune inflammatory response in patients with chronic heart failure and coexisting primary hypothyroidism
by: Yuliia Ihorivna Mykula, et al.
Published: (2022)

Research on the Effects of the Chronic Treatment With Different Doses of Urocortin 2 in Heart Failure Rats
by: Li-Zhen Yang, et al.
Published: (2019)

Spotlight on valsartan–sacubitril fixed-dose combination for heart failure: the evidence to date
by: Vilela-Martin JF
Published: (2016)

Are there benefits of low doses of ACE inhibitors, MRAs, diuretics and statins in the treatment of heart failure?
by: V. А. Lysenko
Published: (2021)

The relationship between serum uric acid level and concentration of proangiogenic endothelial progenitor cells in chronic heart failure patients
by: A. A. Kremzer
Published: (2017)

Medication Optimization and Patient Education in Heart Failure: A Standardized Patient Case for Clerkship Students
by: Kelly Karpa, et al.
Published: (2016)

ENDOTHELIAL DYSFUNCTION IN ISCHEMIC HEART DISEASE
by: N. E. Zakirova, et al.
Published: (2016)

Spirolactone provides protection from renal fibrosis by inhibiting the endothelial–mesenchymal transition in isoprenaline-induced heart failure in rats
by: Zhou H, et al.
Published: (2016)

Angiogenesis in Patients with Chronic Heart Failure: Focus on Endothelial Vascular Growth Factor, Pentraxin-3 and Transforming Growth Factor Beta
by: R. N. Shepel, et al.
Published: (2020)

Case report of optimizer implantation to modulate cardiac contractility in patients with chronic heart failure and atrial fibrillation
by: Pushkareva AE, et al.
Published: (2023)

Optimization of Heart Failure Patients Discharge Plan in Rajaie Cardiovascular Medical and Research Center: An Action Research
by: Fidan Shabani, et al.
Published: (2021)

Vulnerable period in heart failure: a window of opportunity for the optimization of treatment - a statement by Mexican experts
by: José Antonio Magaña Serrano, et al.
Published: (2024)

The Role of Calcium Handling in Heart Failure and Heart Failure Associated Arrhythmias
Published: (2019)

Pneumocystis jirovecii in Spanish Patients With Heart Failure
by: Izarbe Merino-Casallo, et al.
Published: (2019)

In Vitro Endothelial Cell Proliferation Assay Reveals Distinct Levels of Proangiogenic Cytokines Characterizing Sera of Healthy Subjects and of Patients with Heart Failure
by: Rebecca Voltan, et al.
Published: (2014)

Pediatric Heart Failure
by: Iolanda Muntean, et al.
Published: (2021)

Trimetazidine in Heart Failure
by: Hongyang Shu, et al.
Published: (2021)

Bone in heart failure
by: Goran Loncar, et al.
Published: (2020)

Pediatric heart failure
by: Kundan Mittal
Published: (2020)

Corrigendum: Vulnerable period in heart failure: a window of opportunity for the optimization of treatment - a statement by Mexican experts
by: José Antonio Magaña Serrano, et al.
Published: (2024)

Possible approaches to reproduction of endothelial dysfunction. searching for the optimal model
by: I. B. Tsorin, et al.
Published: (2024)

Adverse transverse-tubule remodeling in a rat model of heart failure is attenuated with low-dose triiodothyronine treatment
by: Shimin An, et al.
Published: (2019)

Anaemia in heart failure patients: the prevalence of haematinic deficiencies and the role of ACE inhibitors and aspirin doses as risk factors
by: Guirguis K
Published: (2019)

Rehabilitation in Pediatric Heart Failure and Heart Transplant
by: Ana Ubeda Tikkanen, et al.
Published: (2021)

Phenobarbital Pharmacokinetics and Optimal Dosing of Phenobarbital
by: Safiullah Shareef, et al.
Published: (2018)

Are We Giving Optimal Dose of Efavirenz?
by: Evy Yunihastuti
Published: (2016)